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The
efficacy
of coronary venous reerainfudon or
In
e iron rhetarnr
deferaxamine was studied In 24 penlobarbtral-anestltetited open
chest pigs with a 60 min occlusion of the left anterior descending
coronary artery followed by 3 h of reperrusion, Eight retrogradely
treated pigs were given 10 mgOcg twdy weight of deferoxamme by
was of the anterior interventricular vein and eight sysumirally
treated pigs received the same doses of defero
amine imrave-
nously- Drug infusions tasted for 5 min, beginning 15 min before
reperfuwlon . Eight control pigs received systemic haravennus
saline solution .
Myocardial area at risk and necrotic area were assessed b the
raonastral blue dye and the triphenylletrazolium chloride staintn ;
method, respectively- There were no significant differences
in
Reactive oxygen intermediates Idxvgen-derived free radi-
cals) such as superoxide anion and hydroxyl radical have
been implicated as major determinants of pu,tischumic myo-
cardial dysfunction and reperfusion injury I i .2)
.Oxygcn free
radical scavenging agents given before 13-731 or at the tine
of reperfusion 124-211) have rc.uced pcstischemic dysfune
Lion and reperfusion injury in several animal species 13 281 .
Havever . several studies
(29- ;4) failed to demonstrate such
beneficial effects .
Free Trout (Fcr' I. an abundant ion in myocardial and
endothelial cello . catalyzes the iarm ;
.tion of the highly cytes-
toxic hydroxyl
radicalt
OH) through the Hober-Wets, reac-
tion, which requires a i-ensition :petal 11
.35 .361. The iron
chelamrdckruxamine inhibit, iron-catalyzed fermalion of hy-
droxyl radicals (371 and has redue=.d reperfusion injury in bath
experimental 113 .14,16-20 .22.25-27, and clinical 1381 siudies .
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hernndynamics or regional n-ucardiol function (sonomlerometry)
among the groups
. infarct sine expressed as percent of risk : area
was 71 .9 o 13.506 In the control group, 70
.5 ± 16.4% In the
systemicath treated group aid 485 a 11 .4% Ip K 0.05) in the
reerogradely treated group.
In conclusion, deferoulmlne significantly reduced infarct size
after coronary occlusion only when given regionally by way of the
coronary vein. Because there was no significant hentodynamic
effect caused by deferoxamine infusion, it is suggested that this
drug prevents pmtischemic reperfusion injury by a direct cardio-
pratectene effect.
rl Am Coll Candle! 1991;18e621-7)
logic agent, in the presence of complete coronary artery
occlusion resuilc in substantially higher drug concentration
in the iochemic gone than That achieved with systemic
intravenous administration (39-41) Recent experimental
studies 14 . 1 I)
have showy beneficial effects of oxygen true
radical scavengers given hetcre reperfusiun only when the
crop was delivered regionally by way of a coronary vein
.
Because oxygen free radical scavengers seem to have a local
rather than a systemic effect . ischcmic tissue concentration
of these drugs at the onset of refow stay be critical for
reducing tissue injury and ultimate myocardial infarct size
after reperfusien . In this study . we examined the effective .
nees of retrograde compared with systemic intravenous
infusion of deferoxamine in pig myocardium subjected to
acute ischemia and eeperfusion .
Methods
Animal preparation
. Twenty-nine male or female farm
pigs weighing 2t to 35 kg (mean 39) were included in this
study
. The pigs were fasted overnight and then premeditated
'by intramuscular injection of ketamine hydrochloride
(=0 mg!kc
body weight) and atropine sulfate (0
.04 mg(kg) .
Anesthesia was induced by an intravenous bolus injection
120 to 30 mg/kill and maintained with a continuous infusion
of sodium pentabarbital (2 to 6 mg'kg per h)
. The final dose
and infusion rate were determined by the individual response
673y lo979103.59
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of each pig as judged from observation of its vilil signs . A
tracheotomy was performed and the pigs were ventilated
mechanically by a Harvard respirator- Respiratory rate and
tidal volume werr adjusted to keep arterial blood gases
within the normal range.
Two 5F catheters introduced through the femoral veins
were positioned in the inferior vena cava for administration
of drugs and fluids . A 7F catheter introduced through the left
carotid artery was positioned in the aortic arch to record
aortic blood pressure through a 5tatham P23Db transducer .
An 8F MLKRO .71P catheter transducer (Millar Instruments)
inserted through the right carotid artery was used for mea-
suring left ventricular pressure and its first derivative (dPl
dl). In the relrinfuston group. an SF catheter introducer was
inserted through the left external jugular vein and advanced
into the coronary sinus orifice .
Access to the heart was achieved by a left thoracolomy in
the fifth intercostal space and the pericardium was incised .
The left anterior descending artery was aissecred free and an
adjustable snare was placed around it immediately distal to
its second major diagonal branch . A 4F double lumen
balloon catheter was subsequently inserted through the
coronary venous introducer and its tip positioned in the
anterior inlerventricular vein near the site of the left anterior
descending artery snare .
Two pairs of5 MHz piezoeiecrric ultrasonic crystals were
implanted in the anterior myocardial wall lischemic zone)
distal to the planned occlusion site as well as in the lateral
wall (nonischemic zone) of the kit ventricle . The crystals
were positioned in the mid-myocardium, 10 to 15 mm apart,
and oriented parallel to the minor cardiac axis . Segment
lengths were measured with a sonomicrometer (model 120-
1000, Triton Technology) and percent systolic segment
shortening (%SS) was calculated from the formula : %SS =
l(EDL-ESL)IEDLI x 100, where EDL = end-diastolic
length and ESL = end-systolic length . End-diastolic length
was measured at the beginning of the upstroke of left
ventricular dpfdt ; end-systolic length was measured 20 ms
before the peak negative dPldt .
In the rerroinfasion group, a 22 gauge intravenous cath-
eter (Aagiocath) was imroduc:d iota a branch o€ the anterior
interventricular vein beyond the tip of the relroinfusion
catheter for monitoring of imracoronary venous pressure-
Figure 1 illustrates the method of coronary venous drug
relroinfusion . The central lumen of the relroinfusion cathe-
ter was used far drug infusion. The second lumen was used
for balloon inflation and occlusion of the coronary vein, thus
preventing drug regurgitation into the right atrium,
After instramenrarion, all pigs received 300 lUlkg of
hepatin sodium intravenously supplemented with 100 tU(kg
every 2 h . Limb lead II of the electrocardiogram and
pressures were continuously monitored on an Electronics
for Medicine physiologic recorder
.
Experimental procedure. Aftr coronary artery occlu-
sion, the pigs were randomly assigned to one of three
groups. Group A In = 8) received 10 mg/kg of deferoxamiae
f- teetemw Zunu
i
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Figure 1 . Experimental preparation showing the position of the
snare around the left anteriardescendmg coronary artery (LAD) and
the position of the coronary sinus catheter. AI Vein - anterior
inlervenlricular vein; GCV = great cardiac vein ; LCX = left
circumlkx eomnary artery . Stippled non outlines the ischemic
none .
mesylate (molecular weight 656.8) dissolved in 20 ml of
distilled water through the retroinfrsion catheter over a
period of 5 min, beginning 45 min after coronary artery
occlusion
. In group B (n = 8). the same dose of deferoxam-
ine was given intravenously over a 5 min period, also
beginning 45 min after coronary occlusion-Group C (n = 8)
received the same amount of intravenous saline solution .
During relrindusion. the balloon in the retroperfhsinn
catheter was inflated immediately before and kept inflated
during the 5 min infusion and for an additional 2 min after
completion of retrinfuson. Coronary venous pressures
were monitored during the infusion to avoid excessive
intravenous pressure- Sixty minutes after coronary occlu-
sion . reperfusion was achieved by complete release of the
snare . If ventricular fibrillaeion developed, defibrillation was
attempted with direct current countershocks . However, no
anliarrhylhmie or other pharmacologic agents were given
during the experiments .
Data analysis
. Sequential measurements of hemody-
ttamic and regional left ventricular myocardial function
variables were obtained before coronary artery occlusion
(baseline), 45 and 60 min after occlusion and 30, 60, 120 and
180 min after reperfusion (Fig. 2).
Three hours after reperfusion and after reocclusion of the
coronary artery with a silk suture, 20 ml of Ioa monastral
blue dye was injected into the Left atrium to outline the
underperfused myocardium . The pigs were subsequently_
killed by an intravenous overdose or potassium chloride .
The hearts were excised and sliced into 5 to 7 mm thick slabs
from apex tobase parallel to the atrioventricular groove . The
nometained myocardium representing the risk area was de-
termined by planimetry. The slabs were then incubated in
Group a
. D	mm .roe,gma syam~~~,uy (~ .e)
Group C :
Sauce sysrem¢auy pro)
Figure 2. Study protocol . Deferosamine administration I5 min do -
rationi was begun 45 min alter left anterior descending ILADI
coronary artery occlusion . Asterisks indicate timing of hemody-
namie measurements .
triphenyltetrazolium chloride
. which stains viable myocar-
dium red 142) . Extent of necrosis was also determined by
planimetry and the ratio of necrotic area to risk area calcu-
lated.
Statistical analysis. Data were analyzed using analysis of
variance (ANOVA) with repeated measures . Statistically
significant effects (p < 0 .05) were further investigated with
BonferroniI tests . Values are expressed as mean values
SD.
Table 1 . Hemodynamic Variables During Coronary Occlusion and Reperfusion
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Results
Five of the 29 animals developed ventricular fibrillation
and died after coronary artery occlusion and before random
ization
. Of the 24 survivors (O pigs in each group) . 3 pigs in
group A. 3 pigs in group H and 4 pigs in group C developed
ventricular fibrillation in the early occlusion period before
randomization and underwent successful defbrillation. Only
one pig (group A) developed ventricular fibrillation after
reperfusion : defibrillation was also successful in this pig .
Hemodynamies . Heart rate . systolic and diastolic aortic
blood pressures, left ventricular end-diastolic pressure and
peak positive and negative dPldt are summarized in Table I
.
There were no significant differences among the three groups
in any of the hemodynamic variables analyzed before or
after coronary artery occlusion or during the reperfusion
period .
In each group . heart rate increased and systolic pressure
progressively decreased during the experiments . but these
differences did not reach statistical significance . There were
also no significant changes in left ventricular end-diastolic
pressure throughout the experiments . Peak positive and
negative dPldi decreased progressively during the study, but
there were no statistically significant differences among the
three groups at any time points. In group A (retroinfusion
groups . peak coronary venous presure at the end of retroin-
Values are mean s'nluuu x SD. DAP = diaunlic tonic blood pressure . - and - dPdl = positive and negative fire derivative of tell ventricular pressure .
rcspecllvely: Group A = rcirog,ad,l5 Ireetnd group : Gm up R - s5 vemicully o eared group : (troop C - control pulp : HR = bean rain: LVEDP = lair vcniocular
end.diasmlic pressure: Pre = proncdusion
: SAP = systolic aortic blood pressure .
Occlusicn
Reperfuvon
Pre 45 Mm
WI Mm
10 Mm
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HR (II-11mlnl
Group A 106 o 21 103'_ 16 it) - . I11 - 1_9 111 x23 1m m 24 167 x 24
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19 114 _ 27 I^, - 't 128
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Group, B 1 ..4-11'9 111±1) .11 12.1 :1141 1 .31-11 . I1 1 .24±937
1
.18±1127 1^_7±0
.10
G
:oup C 1
.43 : 027 1 .1 2 : 1121) 1 .35 . 0,21 1 .24 :1) 19 1 .39
9
0 .24 1 .28 = 0 .23 1 .22 7 0 .21
- d0., dt I x lo' mm Hg u
Group A 1 .09 - 0099 0 .26 .91 : 1) 21 11.91 :1125
0.95 x 0 .23
091 ± 0
.24 0.90 x 0 .20
Group B 1 .11
'
a .15 107 z 11.21 0.98
`
4 2t 098 9 ! .00 c 11
.2
0.99 = 0 .20 1
.10 x 025
Group C 1 .13x0 .29 1.115 :0.19 1.08±0
.12
0 .99'0 .19 1 .14x0 .23 IM t0 .19 1 .10
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Table 2, Pervert Systvllt Segment Shortening (0 SSI in ischemic and Noniechemic Zones
Vibes are mean ralecs = S0 . Ikfmll ent as in Table I .
fusion was 52 t 6 mm Hg : no pig had a peak pressure
X60 man Hg .
Unit
ventricular
function . Table 2 shows myocardial sys-
tolic shortening results in both ischemic and nonischemic
zones . Coronary artery occlusion caused paradoxic systolic
segment lengthening (dyskinesia) in the ischemic zones and
function did not improve significantly throughout the exper-
iments in any group . In the nonischemic zones, there was no
significant change in systolic shortening during the experi-
ments .
Myocardial infarct size (Table 3) . The risk area was
similar in all three groups (27 ± 4.5% in group A . (2 .3 s
6 .6% in group B and 30 ± 9 .9% in group C ; p = NS) .
Myocardial infarct size (percent risk areal was significantly
smaller (p < 0 .05) in group A than in group B or C (48 .5 ±
21 .4% in group A versus 70 .6 C 16 .4% in group B and
73 .9 s 13.5% in group C 1.
Moreover, infarct size expressed ax
percent of the risk
wen was similar in the pigs that were successfully resusci-
tated after ventricular fibrillation (41 .3 - 34. 1% in group A-
79 .9 a 7.8171 in group B and 77 ± 12 .1% in group CI and in
pigs that did not develop fibrillation (52 .9 ± 12.1% in group
A, 65 .6
it
199 in group B and 70.8 16% in group C ) .
Discussion
Oxygen free radicals in ischemic perfLsed myc •a ^dlum.
Reperfusion after coronary artery occlusion causes an im-
mediate burst (431 and continued production (44) of oxygen
free radicals, which by their cylotoxic nature can further
damage the jeopardized ischemic tissue and possibly obviate
the potential beneficial ef
fects of reperrusion . There are
several potential sources of oxygen free radical generation in
ischemic-repedused myocardium . The first is the xanthine-
ox, ase system through degradation of adenosine triphos-
phate to hypoxanthine
121.
With the introduction of molec-
Jar oxygen during repetfusion and its subsequent reaction
with hypoxanthine. superoxide anions (0;) are formed Q.
Other sources include activated neutrophils [0 . the cyclo-
oxygenase pathway of arachidonic acid metabolism (1,2) and
electron leakage from the transport system within the mito-
chondria, all of which can generate superoxide anion, hy-
droxyl and other toxic radicals 11 .36.371 .
(ACC Vol . la. No . 2
Maul 1991 :621-7
Deferoxamine, an iron chelator, tnhtbtrs formation offhe
highly rytoroxic hydroxyl radical, which is partly formed
through Lisa usually slow reaction of superoxide with hydro-
gen peroxide (Hatter-Weiss reaction). When catalyzed by
free iron (Fenton reactionl, this reaction speeds up substan-
tially . Reperfusion increases production of superoxide.
Table S
. Left Ventricular Risk Area and Infarct Size
'p 1
0.05 cerise groups B and C . Definitions as in Table I .
Ace cam Rrprrfwlon
lOMin IH
	
2H 3Hpre 45 Min 60Mte
scheme rxSS1
Group A 10a-56 -2
.4-27 -294_5
-16% 3-1 -3
.0 x 3 3 -4 .4 x 3 .1 -2.5 1 3.9
GrmtB
159_39 -46'_4.2 -4 .14 3 .7 -4 .0 27 -4.3'31 -46-_42 -4.3x3.6
GruupC Is6c49 L4 L5 -06-IA -4''4.0 -4.4-6 .3 -4 .3-4.4 -3.3'3.3
9onisrheoiic 11x551
Group A 15 .819 .6 19
.419.4 20 .1*10.7
18
.9 ! 9.8
18
.6 ! R L9 17
.2 `-
10,9 17.2 ± 104
Group 8 17 _
,
4 .0 16.6 s 5.1 164 44 18 .3 .5.6 161 7A 138-66 16.7x6 .3
GraapC 19 .'5 .5 19,0 6 .6 1„0 .5-6.1 17 .8-3.5 11.7-5± 174-5.8 18.0-5 .2
Hit No.
Risk Area Infarct site
k of Len
Ventricle
Yl of Risk
Area
't of 101
Ventrsk
Group A
1 10.4 12.1
59.6
31 .1 1.4 4.7
31 .1 155
49.9
25 9.1 36.2
21.7 10.9 50.1
26 .3 I8 68.6
28 .3 20 .6 72.9
B 32 .4 15 46.4
Mean 27 12 .8' 48.5'
SD 4 .3 6 21.4
Groan a
1 35 .3 30 .5 86 .3
2 23 .3 Ia .S 79 .4
3 99.7 18 .1 63 .2
d
399 99 34 .8
5 294 20.2 68 .7
6 37 51 .1 83 .9
7
31,4 24,3 77 .5
a
44
.9
31 .8 70 .8
Mean
32.3 :3.1 70 .6
SO OR 7.1 16 .4
Group C
1
286
18 .8 65 .8
2 37.5 27.7 73 .9
3 22.5 13.6 60,6
4 24 12.6 52.7
5 47
33 .5 75.3
6 15.3 13 .9 91
7 35.3 30 .8 87.2
S 30 .1 255 64.8
Mean 30 22 .3 73.9
SD
9
.9 8 .8 13.5
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which in its turn increases the amoi :dt of free run normally
bound in the form of ferritin to endothelial cell, .
Retrograde coronary venous drug administration . Rel-
reiofusion of pharmacologic agent, i, air alternative
technique for regional drug delivery to ischemic myocardium
by way of the coronary veins. To promote local delivery to
ischemic myocardium, the drug is infused simultaneously
with balloon inflation at the tip of a specially designed
coronary venous catheter- To avoid possible injury to the
coronary veins, peak coronary venous prennure should nut
be >60 mm Hg (40) . Therefore, coronary venous pressure
must be monitored continuously during retroinfusion to
permit immediate balloon deflation and interruption of the
infusion in the event of excessive pressure .
Ryden ct al. (40) recently demonstrated that coronary
venous retroinfusion resulted in pronounced accumulation
of the beta-adreeergic blocking agent metroprolol in the
ischemic myocardium after coronary artery occlusion in
pigs. with tissue concentrations 10 to 100 times higher than
those obtained with systemic intravenous administration .
Karagueuziart et al . (39) also observed that ventricular
tachycardia could be successfully treated with relatively low
doses of procainamide infused through the great cardiac
vein- which resulted in high tissue procainamide concentru-
lions in the ischemic myocardium of dogs subjected to 24 h
of coronary occlusion
. Conversion to sinus rhythm occurred
in only 3 of 13 episodes of spontaneous sustained tachycar-
dia after systemic procainamide infusions compared with I I
of 13 episodes after retroinfusion . Rctroinfusion was also
more efficacious for preventing induction of ventricular
tachycardia . Other studies 115 .21 .45_491 have shown bene-
ficial effects after retroinfusion but not with systemic admin .
istration of infarct-reducing agents after complete coronary
artery occlusion . Wappel et al . 1491 recently reported signif-
ic inl infarct size reduction with retroinfusion of propranolol
in a dose-dependent fashion, although larger propranolol
dosages were also associated with a significant reduction in
heart rate and mean arterial pressure in their study .
Tire main findings of oar studs' ;,err or fall.r ;sr :
I I deferoxamine delivered by systemic intravenous or coro-
nary venous infusion in the presence of left anterior descend-
ing coronary artery occlusion and reperfusion did not cause
significant hemodynamic effects : 2) deferoxamine did not
affect regional myocardial function in ischemic or nun-
ischemic zones : and 3) deferoxamine significantly reduced
myocardial infarct size after coronary venous but not sys-
temic administration .
Regional myocardial function after reperfusion . It has
been well established in experimental and clinical studies
that early reperfusion of acutely ischemic myocardium im-
proves regiunal let! ventricular function . However . persist-
ent or worsening myocardial dysfunction occurs for several
hours or even days after reperfusion . even in the absence of
myocardial necrosis ("stunning' 1
(501
.
Oxygen free radicals seem to play an important role in
myocardial stunning 112) and free radical scavengers have
been shown to enhance myocardial functional recovery after
KOBAYASHI ET AL .
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reversible ischemia 17 .8 .10-12,15 .21 .?8). In recently pub-
lished studies 114 .171 . deferoxamine administered intrave-
nously before coronary occlusion significantly improved
regional myocardial systolic function in dogs subjected Io
IS min of occlusion and 4 to 5 h of reperfusion, suggesting
that deferoxamine may prevent myocardial stunning .
the lack of improvement in ischemic zone myocardial
function after systemic administration of deferoxamine to
our study is probably related to the duration of coronary
artery occlusion . resulting in large amounts of irreversibly
damaged mvocardium (nearly 71% of the risk area) .which is
not surprising in the pig, an animal known to have poor
collateral blood flow. In pigs treated with retroinfusion of
deferoxamine. infarct size was only 48f/r of the risk area yet
functional improvement was not observed up to 3 h after
reperfusion. It is possible . however, that prolonged periods
of observation after reperfusion would have demonstrated
better functional recovery in these animals compared with
those treated with systemic infusion of deferoxamine .
Myocardial infarct size. Deferoxamine (19 .221 and other
oxygen free radical scavengers (4-6.11 .15,21 .23,24) have
been shown to reduce myocardial infarct size in experimen-
tal animals
. Lesncfsky et al . 119) showed a 60% reduction in
infarct size with intravenous deferoxamine given before
coronary occlusion in dogs subjected to 90 min of ischemia
and 6 h of reperfusion . Reddy et al. (22) reported a 40Sf
reduction in infarct size with intravenous deferoxamine
given before coronary occlusion in dogs undergoing 2 h of
left anterior descending artery occlusion and 4 h of r eperfu-
sion . i n contrast with no infarct size reduction when the drug
was given 5 min before reperfusion .
Na,lund et al . (23) recently reported a 15% reduction in
myocardial infarct size when superoxide dismutase was
given intravenously in
pentobarbital-anesthetized
closed
chess pigs subjected to 60 min ufcoronary occlusion and 24 h
of reperfusion . as opposed to no infarct size reduction after
a 90 min occlusion, Systemic intravenous administration of
deferoxamine did not reduce infarct size recently
published study 1331 in dogs subjected to 2 h of coronary
occlusion and 20 to 24 h of reperfusion . whereas there was a
significant infarct size reduction when the dogs were killed at
4 h of reperfusion 1721. suggesting that the drug delays rather
than prevents irreversible cell damage .
Determinants of efieets on myocardial infarct size. The
effects of oxygen free radical scavengers on infarct size are
still cnmmvcrsiai. Several possible explanations for these
contradictory results have been suggested . including differ-
ence+. in duration of ischemia, animal species . conscious
verso•, anesthetized slate and mode of drug administration .
We believe . however, that the most likely explanation for
these contradictory results lies in the mode of drug admin-
istration . The amount of drug reaching the jeopardized
ischemic zone after systemic intravenous infusion in the
presence of coronary artery occlusion may be insufficient
and therefore ineffective. In most negative studies 129-311 in
the dog
. oxygen free radical scavengers were given as a
prereperfusion continuous infusion, whereas in several pos-
626
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itive studies the drug was giscn before ucelueiua and con-
tinuously during rcpcrItusum 14-7,,19,221 or us a prereperfu-
,ion bolus injection full owed by continuous infusion (241 .
Drug administration before coronary artery occlusion pro-
vides an excellent opportunity to achieve therapeutic drug
concentrations in the m)ocardium . During coronary occlu-
sion. hums injections provide higher peak plasma levels and
may enhance drug concemration in the ischemic zone by
way of coronary collateral flow. Coronary collateral circu-
lation is a major determinant of myocardial infarct size, but
may be equally critical for the access of infarct-reducing
drugs with potentially local beneficial effects such as oxygen
free radical scavengers . In our study, a 357 reduction in
infarct size oh, nhserverl with coronary venous retroinfu-
.inn of defernxamine beginning 15 min before reperfusion .
whereas systemic intravenous administration failed to re-
duce infarct size. which was nearly Cansmural in most pigs
.
Halori ci al
. (21) recently reported a 70%7 reduction in
infarct size after retroinfusion of superoxide dismulase and
catalase in dogs subjected to 90 min of coronary occlusion
and 3 h of reperfusion
. whereas there was only a 307
reduction after systemic intravenous administration . Wappel
et al. 1491 also found that high doses of propranolol admin-
istered by way of the great cardiac vein after coronary
occlusion in dogs resulted in greater myocardial salvage than
that achieved with use of the intravenous route. These data
support the hypothesis that infarct size reduction after
retroinfusion is probably related to enhanced drug delivery
to ischemic myocardium,
Limitations of the study. One limitation of this study is
that we could not obtain myocardial concentrations of de-
feroxamine . however, recent studies from our laboratory
144411 using an identical experimental model have demon-
strated myocardial drug concentrations 10 to 100 times
higher in the ischemic regions after retroinfusion compared
with the same amount of drug given intravenously,
Another limitation is that we did not measure myocardial
blood floss' . Electric coronary collateral circulation is very
limited in pigs and deferoxamine has no apparent effect
on
myocardial blood flow 114,17,19,221, we assume that blood
flow to the ischemic region was low and did not change
significantly after defernxamine administration .
In the present study, a dose of 10 mg/kg of deferoxamine
was selected on the basis of previously published studies (141
showing improved function of stunned myocardium with this
dose
. However, we cannot rule out the possibility of infarct
size reduction with larger doses of deferoxamine given
systemically. Also . we did not rule out a possible effect of
coronary sinus occlusion on infarct size by including in our
study a fourth group of pigs receiving retroinfusion of normal
saline solution alone . However, this step was judged to be
unnecessary on the basis of recent studies from our labora-
tory (48 .511 demonstrating no infarct size reduction with this
procedure .
JACr' Viii . IN. Nn . 2
Aug- 1991'.621-7
Tun it1(kr 24 pie' item 'loped renrrirulur fihrillnrinn in r/rr
acrd- orrhnion period.
Antiarrhythmic agents were not
given because drugs such as liducaine have been shown to
reduce myocardial damage in experimental models of myo-
cardial ischemic 1521. Also . infarct size was probably not
influenced either by the short period of ventricular fibrilla-
tion or by application of direct current countcrshocks in
some pigs because there was no significant difference in
infarct size in pigs within each group that did or did nut
develop ventricular fibrillation . Kerber et al- 1531 showed
that direct tr_picardiah shocks op to Ia0 I did not produce
subendocardial contraction abnormalities measured by so-
nomicrometry 20 min after shock delivery
. Finally, the pigs
in our study were killed after a relatively short 13 hl period of
reperfusion
. Longer periods of observation might have en-
hanced recovery of regional myocardial function or even
shown no differences in infarct size
.
Conclusions
. This struts shows that local delivery of
deferoxamine by way of the coronary veins to acutely
ischemic-reperfused myocardium in pigs reduces infarct
size. but does not improve regional myocardial function far
up to 3 h after reperfusion. The results suggest that this
iron-ehelating agent prevents postischemic reperfusion in-
jury by a direct cardioprotective effect. Furthermore, our
study confirms previous reports of enhanced efficacy of
drugs delivered by way of the coronary venous system in the
presence of complete coronary artery occlusion.
We thank Mr les Prerosl and Willis Cuais Peafor technical assistance . Debra
Scarlalla for expert valklis. l analysis-Ronald Arraga for loping Ihr menu-
"rips
pod Jeaone BI- . for editorial araislance.
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